These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21115155)

  • 21. Mouse models of adrenocortical tumors.
    Basham KJ; Hung HA; Lerario AM; Hammer GD
    Mol Cell Endocrinol; 2016 Feb; 421():82-97. PubMed ID: 26678830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor system on adrenocortical tumorigenesis.
    Ribeiro TC; Latronico AC
    Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
    Fottner Ch; Hoeflich A; Wolf E; Weber MM
    Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.
    Demeure MJ; Stephan E; Sinari S; Mount D; Gately S; Gonzales P; Hostetter G; Komorowski R; Kiefer J; Grant CS; Han H; Von Hoff DD; Bussey KJ
    Ann Surg; 2012 Jan; 255(1):140-6. PubMed ID: 22156929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
    Ribeiro RC; Pinto EM; Zambetti GP
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the ACTH receptor in adrenal tumors: identification of a novel microsatellite marker.
    Zwermann O; Beuschlein F; Klink A; Stahl M; Reincke M
    Horm Metab Res; 2004 Jun; 36(6):406-10. PubMed ID: 15241732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of microRNAs in adrenocortical tumors.
    Singh P; Soon PS; Feige JJ; Chabre O; Zhao JT; Cherradi N; Lalli E; Sidhu SB
    Mol Cell Endocrinol; 2012 Mar; 351(1):118-28. PubMed ID: 21996374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary and adjunctive therapy in carcinoma of the adrenal cortex.
    Bradley EL
    Surg Gynecol Obstet; 1975 Oct; 141(4):507-16. PubMed ID: 1166374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
    Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.
    Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B
    Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
    Schröder S; Padberg B; Reincke M; Komminoth P
    Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
    Faria AM; Almeida MQ
    Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular biology of incidentally diagnosed adrenal gland space-occupying lesion].
    Reincke M; Allolio B
    Zentralbl Chir; 1997; 122(6):430-7. PubMed ID: 9334108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocortical carcinoma. Our experience.
    Favia G; Lumachi F; Carraro P; D'Amico DF
    Minerva Endocrinol; 1995 Mar; 20(1):95-9. PubMed ID: 7651289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy].
    Bertagna X; Groussin L; Libe R; Bertherat J
    Bull Acad Natl Med; 2008 Jan; 192(1):87-102; discussion 102-3. PubMed ID: 18663984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.
    Mazzuco TL; Chabre O; Feige JJ; Thomas M
    Mol Cell Endocrinol; 2007 Feb; 265-266():23-8. PubMed ID: 17250952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal cortex ontogenesis.
    Lalli E
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):853-64. PubMed ID: 21115154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.